Use of molecular pathology in the evaluation of precision animal modelsKeith MansfieldDirectorDiscovery and Investigative PathologyNovartis Institute for Biomedical Research
Discovery and Investigative Pathology
Molecular pathologyKey element in precision medicine
• Molecular pathology is focused on the study and diagnosis of disease through the examination of molecules (generally DNA, RNA and protein) within organs, tissues or bodily fluids.
• It attempts to understand the molecular basis of morphological changes and requires a firm foundation in anatomic pathology.
• It is multi-disciplinary in nature and integrates genomics, genetics, proteomics, and physiology with morphology and utilizes a number of tools including immunohistochemistry and in situ hybridization.
• Molecular pathology tools are frequently used in the clinical diagnosis and management of cancer patients and the discipline is one of the foundations of precision medicine.
2
Discovery and Investigative Pathology
Molecular localization Immunohistochemistry automated work flow
3
• Molecular localization is the ability to define the spatial distribution of molecular entities in tissue.
• Immunohistochemistry has been automated on several platforms increasing efficiency and improving reproducibility.
• Commercial antibody quality and specificity vary widely and appropriate controls are required to qualify reagents.
• Assay validation may include WB, flow cytometry, staining of cell lines and tissues with known levels of expression, peptide blocking experiments, correlation with mRNA data and reproducibility assays.
Discovery and Investigative Pathology
Molecular localization In situ hybridization• In situ hybridization techniques using traditional riboprobes, DNA probes
or LNA probes or next generation probe technology (Affymetrix/Panomics(ViewRNA) and Advanced Cell Diagnostics (RNAscope)) may be adapted to autostaining platforms.
• Next generation technologies can detect splice variants and SNPs.
4Le
ft ve
ntric
leS
mal
l int
estin
e
Variant 1 Variant 2
RNAscope/ViewRNA• Detects single mRNA molecules and provide
quantitative data at single cell resolution.• Provides quantitative measure of RNA per cell.• Easily multiplexed
Splice variant analysis
Discovery and Investigative Pathology5
Highly multiplexed IHC assaysNext-gen IHC
• Imaging mass cytometry/Laser Ablation Inductively Coupled Plasma MS Imaging
• Highly multiplexed (20-30 markers) performed on a single slide.
• Utilizes rare metal labels of antibodies and maintains their 2D spatial orientation allowing virtual reconstruction.
• Requires significant resources to validate protocols.
• Bioinformatics are key to extracting data to the fullest extent.
V. Dubost, NIBR
Discovery and Investigative Pathology
BiobankingComparative molecular pathogenesis
6
• Biobanks containing well curated collections of normal and diseased human biological samples as well as samples from preclinical species and precision models can be used for target and model validation.
• Comparison of diseased human samples to samples from precision models can determine similarities and differences in morphologic and molecular alterations.
• This comparison may inform the selection of models that most closely parallel aspects of the human disease to be investigated.
• Comparisons assists in experimental design of future studies and may reduce the total number of animals needed to complete studies.
Discovery and Investigative Pathology
Molecular localizationComparative molecular pathogenesis
7
Upregulation of p22phox and Nox2 mRNA in CCl4 liver fibrosis model
Alterations in p22phox and Nox2 mRNA not detected in septal fibroblasts in human cirrhosis
Control mouse liver
Mouse model
Normal human liver
Cirrhotic human liver
Mouse Human
NADPH oxidases contribute to TGF-β1-induced α-SMA production and mediate TGF-β1-induced fibroblast differentiation into myofibroblasts.
• Side by side evaluation of normal and diseased human and animal tissues can inform the comparative relevance of animal models and their potential limitations.
Discovery and Investigative Pathology8
Molecular localizationComparative molecular pathology of pancreatic adenocarcinoma
Stromal component• Neoplastic EMT• Cancer associated fibroblasts• Vascular endothelium• Lymphatic endothelium• Pericytes• Adipocytes
Immune component• T and B lymphocytes• Tregs, NK and NKT cells• Tumor associated macrophages• Myeloid suppressor cells• Tumor-associated neutrophils• Myeloid dendritic cells
Epithelial component• Neoplastic cells• Residual acinar and ductular
pancreatic cells
How do mouse models reproduce elements of this microenvironment?
Discovery and Investigative Pathology9
H&E Stroma T cells B cells ProliferationMacrophageEpithelium
Molecular localizationComparative molecular pathology of pancreatic adenocarcinoma
Vimentin CD3 CD19 Ki67CD68cytokeratin
Vimentin CD3 B220 Ki67F4/80cytokeratin
Vimentin CD3 B220 Ki67F4/80cytokeratin
CD3 B220 Ki67F4/80cytokeratin
CD3 B220 F4/80 Ki67
Vimentin
Vimentin
Patient sample: pancreatic
adenocarcinoma
Xenograft: PANC cell line in
NSG mouse
Syngeneic: engineered pancreatic
organoid mouse
Syngeneic: engineered pancreatic
organoid in NSG mouse
Xenograft: HPAFII cell line in NSG mouse
cytokeratin
Discovery and Investigative Pathology
Digital pathologyWork flow
10
ArchiveArchive
Traditional work flow
Rep
ort
• Digital archive with metadata • Available for virtual
microscopy, image analysis, data mining and other bioinformatic approaches
Rep
ort
Digital pathology work flow
Discovery and Investigative Pathology
Image analysisWhole slide image analysis
11
Perform IHC/ISH and slide scan
Image analysis soft ware trained to identify tissue
typesCell segmentation and
staining intensity scoredQuantitative data
exported and integrated with sample metadata
CD3 IHC
• Digital pathology facilitates whole slide image analysis.
• Quantitative measures of staining intensity, cell number, cell morphology and relative spatial distribution of specific cell types can be obtained.
Digitized slide Cell segmentation markupTissue segmentation markup
Discovery and Investigative Pathology12
Tissue microarraysMolecular profiling of tissue types
• Tissue microarrays (TMA) can be used for IHC and ISH on automated staining platforms to examine variation in target biology.
• 24-96 cores can be arrayed on an individual slide.
• Custom TMAs can be constructed to array tissues from a single species, disease process or organ from multiple species.
• Quality control of source material is paramount and may be lacking in some commercially available TMAs.
Discovery and Investigative Pathology
Image analysisTissue microarrays
13Im
age
Ana
lysi
s H
-Sco
re
Perform IHC and scan Tissue microarray
Image analysis soft ware identifies and assigns cores
Cell segmentation and staining
intensity scored
Data heat map produced from
Image analysis H-score
Quantitative H-scores can be integrated with
sample metadata
• Quantitative image analysis techniques can be applied to tissue microarrays to facilitate high through put analysis of molecular localization studies and integration with sample metadata
Discovery and Investigative Pathology
Image analysisSpatial resolution of target expression
14
Scale (spot no.)
Control
Treatment
In situ hybridization with single mRNA molecule resolution
Individual dot density converted to intensity heatmap to assist in data visualization
• Image analysis techniques can assist in the spatial resolution of target mRNA expression.
Discovery and Investigative Pathology
Genomic profilingIntegration with molecular localization
15
• Genomic expression profiling can be coupled with morphologic interpretation of tissue to assist in elucidating the pathogenesis of disease.
• Paired samples are routinely taken for genomic profiling and processing for histological analysis.
• Analysis is complex as changes in overall gene expression may result from alterations in individual cells and from changes in the cellular composition of tissue.
• Molecular localization studies can be used to confirm expression changes and cellular source.
Target A
Target B
Target A Target B
Discovery and Investigative Pathology
Genomic profilingCell-type related signatures can be extracted from a complex tissue
Kidney: an heterogenous tissue
Nephrin 1
Podocyte
Clcnkb Nphs1
Cldn5 Pdpn
Clic3 Podxl
Cst3 Sema3g
Ddn Sparc
Gja5 Tnnc1
Nes Wt1
Glomerularendothelial cellAdamts5Anxa1CpeEdnrbLyve1OgnPlatTjp1
MesangialcellActn1Anxa2Anxa5Col4a1Col4a2CygbFlnaTagln2Vim
16
Discovery and Investigative Pathology
PodocyteClcnkbCldn5Clic3Cst3DdnGja5NesNphs1PdpnPodxlSema3gSparcTnnc1Wt1
Glomerularendothelial cell
Adamts5Anxa1CpeEdnrbLyve1OgnPlatTjp1
MesangialcellActn1Anxa2Anxa5Col4a1Col4a2CygbFlnaTagln2Vim
Genomic profilingCell-type related signatures are validated by Immuno-histochemistry and in situ hybridization
Ogn
Anxa5
Pdpn
PodxlSema3g
Tjp1
Cst3
17
Discovery and Investigative Pathology
Summary• Molecular pathology advances our understanding of comparative
pathogenesis of human disease and relevant animal models.
• It is a rapidly advancing field that requires the integration of traditional anatomic pathology skills with molecular biology and bioinformaticapproaches.
• Interrogation of tissues from precision models must be made in conjunction with evaluation of human diseased tissues to better understand the model’s relevance and limitations.
• Future advances will build on of the use of bioinformatics, highly multiplexed localization assays and computational interrogation of digital slide databases.
18
Discovery and Investigative Pathology
AcknowledgementsNovartis Institutes for Biomedical Research• C Buono
• K Wharton
• C Saravanan
• D Stiehl
• P Moulin
• V Dubost
• Z Chen
• J Judge
19